Home  »  Stocks to Invest   »  ReWalk Robotics Ltd. (RWLK) Stock on a Rising Traj...

ReWalk Robotics Ltd. (RWLK) Stock on a Rising Trajectory, Here’s Why

ReWalk Robotics Ltd. (RWLK), a medical device company, has surged 52.71% in aftermarket trading session and consequently is trading at $1.97 at the time of the writing. The surge could be attributed to the FDA’s award of breakthrough device designation to ReWalk ReBoot Soft Exo-Suit. On Thursday, RWLK closed the day at $1.29 after declining 1.53% during the mid-day session.

Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report


Why RWLK Surging

In the late hours of Thursday, RWLK announced that FDA has granted its ReBoot device with designation as a Breakthrough device. The device is a battery-powered, light in weight orthotic exo-suit. It is intended to assist the ambulatory functions in people with declined functioning of ankles. It is a customizable device and intended to be used at home. ReStore device, a device that was approved by FDA in 2019, is a sister product of ReBoot.

Closure of Offering

On 29th September, RWLK announced the closing of its previously announced registered direct offering. The offering was priced at the market in pursuance of the NASDAQ rules. It was intended for the sale of 16,013,518 of the Company’s ordinary shares at a purchase price of $2.035 per share. The company estimated that the gross proceeds from the offering would be around $32.5 million. H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.

Q2 2021 Financial Results

On 9th August, RWLK reported the financial results for the second quarter of the fiscal year 2021. The quarter ended on 30th June. The company generated total revenue of $1.4 million during the quarter against $1.7 million for the same period of 2020. The total operating expenses for the period were $3.9 million against $3.6 million for the same period of 2020. The company suffered a net loss of $3.1 million during the quarter against $2.9 million for the same period of 2020. On 30th June 2021, the company had $64.2 million in terms of cash.  

Executive Commentary

Larry Jasinski, Chief Executive Officer of RWLK, while commenting on the results said that the second-quarter results reflect the ongoing reopening of the markets. He expatiated that the company is expanding its resources to achieve its goals.

Future Outlook for RWLK

RWLK has not seen a rapid decline or surge during the last 12 months, which depict that the minimal stimulating factors acted on the company during the period. However, estimates suggest that the company is in a good position to take its business forward in the coming quarters.

Leave a Comment

Your email address will not be published. Required fields are marked *

Related Posts




The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.

Receive Best Stock To Trade Before The Opening Bell



100% Free. Stop Anytime. No Spam